Validation of Mechanism Based Inhibition: Our Experience Franca Pugnaghi, Craig Thomas, Rachael Brown and Peter Fenn Aptuit Limited, Riccarton, Edinburgh EH14 4AP, UK

First Page		Document Content
Date: 2015-02-05 10:57:53 Metabolism Catalysis CYP2A6 Enzyme kinetics CYP2D6 Enzyme Methoxsalen Paroxetine CYP2E1 Chemistry Cytochrome P450 Enzymes		Validation of Mechanism Based Inhibition: Our Experience Franca Pugnaghi, Craig Thomas, Rachael Brown and Peter Fenn Aptuit Limited, Riccarton, Edinburgh EH14 4AP, UK Add to Reading List Source URL: www.aptuit.com Download Document from Source Website File Size: 963,58 KB Share Document on Facebook

	Validation of Mechanism Based Inhibition: Our Experience Franca Pugnaghi, Craig Thomas, Rachael Brown and Peter Fenn Aptuit Limited, Riccarton, Edinburgh EH14 4AP, UK DocID: 1awSi - View Document
	Proc. R. Soc. B, 1231–1241 doi:rspbPublished online 19 March 2008 Review DocID: 14GIi - View Document
	Seminar Invitation The National Research Centre for Environmental Toxicology (Entox) invites you to the seminar Potential Role for p53 and Nrf2 in Regulating the Expression of Human Cytochrome P450 2A6 Gene Presenter: Mr DocID: 11xl2 - View Document
	British Journal of Cancer[removed], 1126 – 1134 & 2011 Cancer Research UK All rights reserved 0007 – [removed]www.bjcancer.com CYP2A6 and ERCC1 polymorphisms correlate with efficacy DocID: RVsO - View Document
	1 TE Chandra Prakash and Alfin D. N. Vaz RI DocID: nNcB - View Document